Supplementary Data from Biomaterial Scaffolds Recruit an Aggressive Population of Metastatic Tumor Cells <i>In Vivo</i>

Abstract

&lt;p&gt;1. Fig S1: Gating strategy for flow cytometric assays 2. Fig S2: Metastatic lung tumor burden for LUNG and LUNG2 lines developed from mice with and without scaffolds 3. Fig S3: Mutational analysis of cell lines by whole exome sequencing 4. Table S1: Table of unique mutations identified for each cell line by whole exome sequencing 5. Table S2: Table of Gene ontology terms significantly altered in genes with mutations in SCAF, PT and LUNG cell lines 6. Fig S4: RNAseq supplemental information 7. Fig S5: Schematic of multiscale Hi-C analysis 8. Fig S6: Hi-C does not reveal additional copy number variations, translocations, or breakpoint mutations between SCAF and PT cell line. 9. Table S3: Table of KEGG pathways investigated for structure/function changes&lt;/p&gt;